Lexicon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $26,554 | $1,750 | $1,647 | $1,130 |
Gross Profit | 26,206 | 1,679 | 1,481 | 955 |
EBITDA | -29,783 | -60,123 | -51,079 | -44,453 |
EBIT | -29,908 | -60,249 | -51,218 | -44,597 |
Net Income | -33,766 | -64,811 | -53,429 | -48,397 |
Net Change In Cash | 26,554 | 1,750 | 1,647 | 1,130 |
Free Cash Flow | -21,965 | -53,926 | -48,790 | -55,130 |
Cash | 66,656 | 34,551 | 35,617 | 96,494 |
Basic Shares | 340,761 | 361,492 | 310,836 | 245,390 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $31,081 | $1,204 | $139 | $298 |
Gross Profit | 30,465 | 1,119 | -288 | -54,748 |
EBITDA | -184,290 | -163,464 | -98,737 | -86,664 |
EBIT | -184,824 | -164,018 | -99,164 | -86,956 |
Net Income | -200,403 | -177,119 | -103,128 | -88,268 |
Net Change In Cash | 31,081 | 1,204 | 139 | 298 |
Cost of Revenue | -17,720 | -62,198 | ||
Free Cash Flow | -179,811 | -162,367 | -90,177 | -88,238 |
Cash | 66,656 | 22,465 | 46,345 | 64,065 |
Basic Shares | 320,031 | 221,130 | 165,733 | 145,652 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.18 |
2024-06-30 | -$0.17 |
2024-03-31 | -$0.20 |
